Chemxpert Database’s Post

Top Drugs Losing Patent Protection in 2025 The pharmaceutical landscape is set for major shifts in 2025 as several blockbuster drugs lose their patent protection. This opens the door for generics and biosimilars, driving market competition and innovation. Stay ahead of the curve with Lifescience Intellipedia Pvt. Ltd. —your trusted partner in pharmaceutical insights. 📈 Discover the impact on market dynamics, opportunities for growth, and strategies to stay competitive. Reach out to us for detailed analysis and insights! 📩 #PatentExpiry2025 #PharmaInsights #LifescienceIntellipedia #MarketTrends #PharmaInnovation #Biosimilars #HealthcareLeadership

Top Drugs Losing Patent Protection in 2025 The pharmaceutical landscape is set for major shifts in 2025 as several blockbuster drugs lose their patent protection. This opens the door for generics and biosimilars, driving market competition and innovation. Stay ahead of the curve with Lifescience Intellipedia Pvt. Ltd. —your trusted partner in pharmaceutical insights. 📈 Discover the impact on market dynamics, opportunities for growth, and strategies to stay competitive. Reach out to us for detailed analysis and insights! 📩 #PatentExpiry2025 #PharmaInsights #LifescienceIntellipedia #MarketTrends #PharmaInnovation #Biosimilars #HealthcareLeadership

Top Drugs Losing Patent Protection in 2025 The pharmaceutical landscape is set for major shifts in 2025 as several blockbuster drugs lose their patent protection. This opens the door for generics and biosimilars, driving market competition and innovation. Stay ahead of the curve with Lifescience Intellipedia Pvt. Ltd. —your trusted partner in pharmaceutical insights. 📈 Discover the impact on market dynamics, opportunities for growth, and strategies to stay competitive. Reach out to us for detailed analysis and insights! 📩 #PatentExpiry2025 #PharmaInsights #LifescienceIntellipedia #MarketTrends #PharmaInnovation #Biosimilars #HealthcareLeadership

Understanding the Impact of Drug Patent Expiry on Prices In the ever-evolving pharmaceutical landscape, the expiration of drug patents plays a critical role in shaping pricing trends and access to medications. Our latest blog post delves into recent trends and insights regarding how patent expirations can lead to significant price reductions, increased competition, and ultimately, greater accessibility for patients. Curious about how these changes might affect you or your organization? Dive into the full article for a comprehensive analysis! Read more here: https://lnkd.in/gv-8k2EH #Pharmaceuticals #Healthcare #DrugPricing #PatentExpiry #Generics #AccessToMedicine

𝗠𝗮𝘀𝘁𝗲𝗿𝗶𝗻𝗴 𝗽𝗿𝗶𝗰𝗶𝗻𝗴 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗳𝗼𝗿 𝗮 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗚𝗲𝗿𝗺𝗮𝗻 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗰𝗼𝗺𝗽𝗮𝗻𝘆! InsiMine collaborated with a pharmaceutical leader to overcome critical challenges in pricing a groundbreaking therapeutic in Germany’s highly regulated market. Using advanced ML algorithms, analog assessments, and regulatory-aligned analytics, our solution delivered precision pricing, accelerated market entry, and optimized profitability. Read the full case study: https://lnkd.in/gMuPDFpE #pharmaceuticalpricing #marketaccess #machinelearning #healthcareanalytics #germanyhealthcare #AMNOG #GKVFinStG

🔔 Delve into details of the shift from Rx to OTC. In the blog, our expert, Karina J., discusses the essential elements for a successful reclassification. 🌐📈Discover how pharmaceutical companies can tap into new markets and directly reach consumers: https://lnkd.in/dvP3wEgK #Pharma #OTC #RxSwitch #PatientSafety #Insuvia

Drug products containing HPAPIs are becoming an increasingly important part of the pharmaceutical outsourcing market, and their growth is showing no signs of slowing down. Bringing HPAPIs into a facility and scaling up through development presents substantial challenges requiring experience and expertise across many fields. In this roundtable report, PCI Pharma Services Kerry Kingdom is joined by industry experts to discuss the complexities of tech transfer and new product introduction in a high potent, multi-product facility. https://lnkd.in/eU2iZmRV #CDMO #HPAPI #PharmaOutsourcing #LetsTalkFuture

Psychedelic drug development is quickly becoming a new frontier in the pharmaceutical industry! Read our latest article to learn about: ✔️ FDA draft guidance and overcoming regulatory hurdles ✔️ Responsibility towards use and ethical challenges ✔️ Key considerations and recommendations It’s a quick 5-minute read: https://hubs.li/Q02v0z5S0 #psychedelics #clinicalresearch #drugdevelopment

A consortium of health technology assessment (HTA) agencies has released a white paper that aims to help pharmaceutical manufacturers provide better data on using surrogate endpoints to demonstrate drug effectiveness and to help HTAs make better decisions on long-term efficacy outcomes. Joanne S. Eglovitch reports in Regulatory Focus: https://hubs.la/Q0343q5N0

Under the current economic model for drug development, creating new antibiotics is not appealing for most pharmaceutical companies. A new act aims to change that. #healthcare #pharmaceuticals #lifescience https://bit.ly/4fKx4ax